Lou Gehrig’s disease

Slowing the progression of ALS using CRISPR – in mice
CRISPR base editing decreased the amount of a mutant protein (blue) that contributes to ALS
A promising drug treatment could revolutionize the treatment of patients suffering from ALS

University of Alberta scientists find a new application for an existing drug, with potential to

New Therapy Delays Muscle Atrophy in Lou Gehrig’s Disease Mouse Model

Mouse study could provide foundation for future human therapeutics Supplementing a single protein found in

New therapy copper-ATSM halts progression of Lou Gehrig’s disease in mice

Researchers at Oregon State University announced today that they have essentially stopped the progression of

English: Amyotrophic lateral sclerosis MRI (axial FLAIR) demonstrates increased T2 signal within the posterior part of the internal capsule, consistent with the clinical diagnosis of ALS source:Radiopedia.org (Photo credit: Wikipedia)
Findings point toward one of first therapies for Lou Gehrig’s disease

Researchers have determined that a copper compound known for decades may form the basis for

Lou Gehrig’s Disease: From Patient Stem Cells to Potential Treatment Strategy in One Study

Translational Research Goes Seamless: After Creating Neurons From Patients’ Skin Cells, Cedars-Sinai-led Researchers ‘Treat’ Gene